Olivia Atkins
Aberdeen bought the portfolio from DIF's maiden fund, which closed on €121m in 2005.
Direct secondaries are set to rise in Asia, where there are guaranteed exit options and more than 6 percent growth says Lucian Wu, the newly-appointed managing director in Auda’s Hong Kong office.
MLC Australia, the wealth management division of the National Australia Bank, has sold several private equity fund stakes this year.
The Wellcome Trust recently sold its stake in Amadeus II, which invested in fibre optics maker Southampton Photonics.
Pictet has most recently sold its stake in EQT VI, which has invested in Danish plastic food tray manufacturer Færch Plast and Finnish mobile phone company Vertu.
Few firms invest in biotech and life sciences secondaries because it can be difficult to evaluate the portfolios, says Johannes Rabini, managing director of Berlin-based Sobera Capital.
BC European Capital IX portfolio companies include Scandinavian cable company Com Hem.
The Edmond de Rothschild spin-out co-led the restructuring of Octopus Investments' Titan VCT fund which managed Graze snack boxes.
Abingworth Bioventures III and IV invested in bone and joint medication company Galápagos and women's health company Gynesonics, respectively.
The companies include Danish network adapter manufacturer Napatech and Aspiro, which owns Norwegian music streaming service Wimp.